Cargando…
Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial
BACKGROUND: The treatment of insomnia, which is the most common sleep disorder, includes drug and behavioral treatment, but each treatment measure has its limitations. So new treatment method needs to be taken to improve the treatment effect. MN supplementation is a potential promising new method fo...
Autores principales: | Gao, Xiangyang, Li, Junhua, Xu, Sanping, Li, Xueying, Wang, Xicheng, Li, Yongli, Huang, Yan, Liu, Shaohui, Zeng, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193321/ https://www.ncbi.nlm.nih.gov/pubmed/37202819 http://dx.doi.org/10.1186/s13063-023-07351-8 |
Ejemplares similares
-
β-nicotinamide mononucleotide (NMN) production in Escherichia coli
por: Marinescu, George Cătălin, et al.
Publicado: (2018) -
Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns
por: Nadeeshani, Harshani, et al.
Publicado: (2021) -
NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
por: Alegre, Gabriela Fabiana Soares, et al.
Publicado: (2023) -
Size Exclusion Chromatography Method for Purification of Nicotinamide Mononucleotide (NMN) from Bacterial Cells
por: Marinescu, George Cătălin, et al.
Publicado: (2018) -
Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise
por: Uddin, Golam Mezbah, et al.
Publicado: (2017)